Winklevoss’ Zcash company pivots to cancer drug after $37.8M loss
Unless the price of ZEC rallies, Cypherpunk Technologies says it will need to raise a lot of money to pay for its upcoming FDA trials.
Read more (3 min) →2 stories, newest first
Unless the price of ZEC rallies, Cypherpunk Technologies says it will need to raise a lot of money to pay for its upcoming FDA trials.
Read more (3 min) →The BTC Yield of MSTR stock in Michael Saylor’s treasury company, Strategy, has turned negative this quarter for the first time in years.